glp-1 kidney disease news Glucagon-like Peptide Receptor Agonists and Outcomes in the Era of Personalized Medicine: Focus on Albuminuria GLP-1 treatments improve kidney function
Description
That is by design
Amanda Banks, one of the studys authors, called the trend troubling, particularly as telehealth companies have made it easier for patients to access the drugs
It needs to be a small molecule (typically under 500 daltons in molecular weight)

There are thousands of studies showing food and exercise is often the best medicine to prevent and reverse disease

pmid:26341938 65

These associations remained consistent across subgroup analyses, including patients using tirzepatide as adjunctive therapy to other first-line diabetes agents, among patients older than 60 and comparisons against individual GLP-1 drugs, including semaglutide and dulaglutide
